SCHEMBL4557518

SCHEMBL4557518

CC(C(=O)O)c1ccccc1OC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.50
PTGS1 P23219 6/20 0.50
ELANE P08246 1/20 0.46
KMT2A Q03164 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.41
CXCL8 P10145 2/20 0.41
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
MMP12 P39900 2/20 0.41
MMP13 P45452 2/20 0.41
MMP14 P50281 2/20 0.41
MMP16 P51512 2/20 0.41
MMP1 P03956 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ESR1 P03372 1/20 0.40
ITGB3 P05106 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28580702 0.86 PTGS2 (0.55) PTGS2PTGS1ELANEKMT2ACXCL8
SCHEMBL2729150 0.84 CYP1A2 (0.48) KMT2AIRAK4TSHRLMNA
SCHEMBL6515789 0.82 PTGS2 (0.49) PTGS2PTGS1ELANEKMT2AIRAK4
SCHEMBL8473051 0.82 PTGS2 (0.64) PTGS2PTGS1KMT2AMMP2MMP9
SCHEMBL7885098 0.82 PTGS2 (0.64) PTGS2PTGS1KMT2AMMP2MMP9
SCHEMBL362211 0.82 PTGS2 (0.64) PTGS2PTGS1KMT2AMMP2MMP9
SCHEMBL10456136 0.79 TSHR (0.39) KMT2ACXCL8KDM4EALDH1A1HPGD
SCHEMBL10456134 0.79 TSHR (0.39) KMT2ACXCL8KDM4EALDH1A1HPGD
SCHEMBL6838437 0.78 TSHR (0.50) KMT2AIRAK4KDM4EALDH1A1TSHR
SCHEMBL1345669 0.77 PTGS1 (0.54) PTGS2PTGS1KMT2ACXCL8MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635822-A4 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARM INC (US) 2009-06-24 EP disclosed
EP-1635822-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
WO-2005000246-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARMACEUTICALS, INC. (US) 2005-01-06 WO disclosed